Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.
Burcher KM, Lantz JW, Gavrila E, Abreu A, Burcher JT, Faucheux AT, Xie A, Jackson C, Song AH, Hughes RT, Lycan T Jr, Bunch PM, Furdui CM, Topaloglu U, D'Agostino RB Jr, Zhang W, Porosnicu M.
Burcher KM, et al. Among authors: jackson c.
Cancers (Basel). 2021 Nov 16;13(22):5733. doi: 10.3390/cancers13225733.
Cancers (Basel). 2021.
PMID: 34830888
Free PMC article.